Roche stops diabetes drug's development after safety questions
ZURICH (Reuters) - Roche said it would stop developing aleglitazar, a diabetes treatment, due to safety reasons and lack of effectiveness.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/8iS3FOu2ddY/story01.htm
No comments:
Post a Comment